The chromosomal microarray market is experiencing sustained growth due to its expanding role in genetic diagnostics, particularly for detecting chromosomal abnormalities associated with developmental ...

In a clinical report issued by the American Academy of Pediatrics and published online June 23 in Pediatrics, guidance is ...

A tiered agnostic approach is proposed based on diagnostic yield and practical considerations: Tier 1: genome or exome ...

Microarray-Based Prenatal Diagnosis for the Identification of Fetal Chromosome Abnormalities Lisa G Shaffer; Jill A Rosenfeld Disclosures Expert Rev Mol Diagn. 2013;13 (6):601-611.

Chromosome microarray analysis, which looks for genetic differences at a larger scale, is also endorsed as a complementary approach.

Liquid bead microarray assembly, hybridization and target identification Multiplex PCR is a powerful way to simultaneously interrogate multiple genetic loci in a single reaction.

Facility brings advanced genetic testing capabilities to West Bengal, including prenatal, oncology, and rare disease ...

Microarray technology has undergone a rapid evolution. With widespread interest in large-scale genomic research, an abundance of equipment and reagents have now become available and affordable to ...

DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by ...

Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low.

Biochip Market is Segmented by Type (Microarrays, Microfluidics), by Application (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes).

Suraksha Diagnostics launched eastern India's largest genomics lab in Kolkata, investing Rs 22 crore with plans for further ...